Literature DB >> 25688395

Shouldn't we care about the biology of benign tumours?

Adrian Marino-Enriquez1, Christopher D M Fletcher2.   

Abstract

While focusing on malignant tumours seems medically reasonable, from a biological perspective, benign and malignant tumours provide complementary and perhaps equally relevant perspectives on the mechanisms of tumour invasion and metastasis. However, the biology of benign neoplasms is rarely studied.

Entities:  

Mesh：

Year:  2014        PMID： 25688395     DOI： 10.1038/nrc3845

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


  11 in total

1.  A progression puzzle.

Authors:  René Bernards; Robert A Weinberg
Journal:  Nature       Date:  2002-08-22       Impact factor: 49.962

Review 2.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

Review 3.  Tumors as organs: complex tissues that interface with the entire organism.

Authors:  Mikala Egeblad; Elizabeth S Nakasone; Zena Werb
Journal:  Dev Cell       Date:  2010-06-15       Impact factor: 12.270

4.  Metastasizing "benign" cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases.

Authors:  Leona A Doyle; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2013-04       Impact factor: 6.394

Review 5.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

6.  Characterization of uterine leiomyomas by whole-genome sequencing.

Authors:  Miika Mehine; Eevi Kaasinen; Netta Mäkinen; Riku Katainen; Kati Kämpjärvi; Esa Pitkänen; Hanna-Riikka Heinonen; Ralf Bützow; Outi Kilpivaara; Anna Kuosmanen; Heikki Ristolainen; Massimiliano Gentile; Jari Sjöberg; Pia Vahteristo; Lauri A Aaltonen
Journal:  N Engl J Med       Date:  2013-06-05       Impact factor: 91.245

Review 7.  Genetic determinants of cancer metastasis.

Authors:  Don X Nguyen; Joan Massagué
Journal:  Nat Rev Genet       Date:  2007-05       Impact factor: 53.242

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

9.  Dystrophin is a tumor suppressor in human cancers with myogenic programs.

Authors:  Yuexiang Wang; Adrian Marino-Enriquez; Richard R Bennett; Meijun Zhu; Yiping Shen; Grant Eilers; Jen-Chieh Lee; Joern Henze; Benjamin S Fletcher; Zhizhan Gu; Edward A Fox; Cristina R Antonescu; Christopher D M Fletcher; Xiangqian Guo; Chandrajit P Raut; George D Demetri; Matt van de Rijn; Tamas Ordog; Louis M Kunkel; Jonathan A Fletcher
Journal:  Nat Genet       Date:  2014-05-04       Impact factor: 38.330

10.  Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.

Authors:  David Dankort; David P Curley; Robert A Cartlidge; Betsy Nelson; Anthony N Karnezis; William E Damsky; Mingjian J You; Ronald A DePinho; Martin McMahon; Marcus Bosenberg
Journal:  Nat Genet       Date:  2009-03-12       Impact factor: 38.330
View more
  7 in total

Review 1.  The hallmarks of premalignant conditions: a molecular basis for cancer prevention.

Authors:  Bríd M Ryan; Jessica M Faupel-Badger
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

2.  Limitations of the Driver/Passenger Model in Cancer Prevention.

Authors:  Mary K Kuhner; Rumen Kostadinov; Brian J Reid
Journal:  Cancer Prev Res (Phila)       Date:  2016-03-01

Review 3.  Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.

Authors:  Shengming Zhu; Jiangang Wang; Lucas Zellmer; Ningzhi Xu; Mei Liu; Yun Hu; Hong Ma; Fei Deng; Wenxiu Yang; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2022-07-04       Impact factor: 4.478

4.  Differentially Expressed MicroRNAs in Meningiomas Grades I and II Suggest Shared Biomarkers with Malignant Tumors.

Authors:  Mohamed Raafat El-Gewely; Morten Andreassen; Mari Walquist; Anita Ursvik; Erik Knutsen; Mona Nystad; Dag H Coucheron; Kristin Smistad Myrmel; Rune Hennig; Steinar D Johansen
Journal:  Cancers (Basel)       Date:  2016-03-03       Impact factor: 6.639

5.  Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome.

Authors:  Helen R Davies; Kirsty Hodgson; Edward Schwalbe; Jonathan Coxhead; Naomi Sinclair; Xueqing Zou; Simon Cockell; Akhtar Husain; Serena Nik-Zainal; Neil Rajan
Journal:  Nat Commun       Date:  2019-10-17       Impact factor: 14.919

6.  Age-Related Metabolic Pathways Changes in Dental Follicles: A Pilot Study.

Authors:  Victor Coutinho Bastos; Jéssica Gardone Vitório; Roberta Rayra Martins-Chaves; Flávia Leite-Lima; Yuri Abner Rocha Lebron; Victor Rezende Moreira; Filipe Fideles Duarte-Andrade; Thaís Dos Santos Fontes Pereira; Lucilaine Valéria de Souza Santos; Liséte Celina Lange; Adriana Nori de Macedo; Gisele André Baptista Canuto; Carolina Cavaliéri Gomes; Ricardo Santiago Gomez
Journal:  Front Oral Health       Date:  2021-06-18

Review 7.  The Molecular Pathology of Odontogenic Tumors: Expanding the Spectrum of MAPK Pathway Driven Tumors.

Authors:  Letícia Martins Guimarães; Bruna Pizziolo Coura; Ricardo Santiago Gomez; Carolina Cavalieri Gomes
Journal:  Front Oral Health       Date:  2021-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.